e-learning
resources
Paris 2018
Monday, 17.09.2018
Diagnosis, prognostication and treatment of pulmonary embolism
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The value of on-admission serum Sodium level on 30-day outcome in acute pulmonary embolism
e. firoozehi (tehran, Islamic Republic of Iran), N. Faraji (tehran, Islamic Republic of Iran), H. Abtahi (tehran, Islamic Republic of Iran), S. Peiman (tehran, Islamic Republic of Iran)
Source:
International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism
Session:
Diagnosis, prognostication and treatment of pulmonary embolism
Session type:
Thematic Poster
Number:
3120
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
e. firoozehi (tehran, Islamic Republic of Iran), N. Faraji (tehran, Islamic Republic of Iran), H. Abtahi (tehran, Islamic Republic of Iran), S. Peiman (tehran, Islamic Republic of Iran). The value of on-admission serum Sodium level on 30-day outcome in acute pulmonary embolism. 3120
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
The signifigance of NT-proBNP value pulmonary tromboembolism in early mortality
Source: Annual Congress 2006 - Pulmonary embolism
Year: 2006
A risk score of adverse short-term clinical outcomes in patients with acute pulmonary embolism (PE)
Source: Eur Respir J 2005; 26: Suppl. 49, 271s
Year: 2005
Prognostic value of two clinical scores in patients with acute symptomatic pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011
Elevated cardiac troponin I levels in acute pulmonary embolism predict increased long-term mortality
Source: Eur Respir J 2005; 26: Suppl. 49, 271s
Year: 2005
Clinical in-hospital mortality profile of pulmonary embolism
Source: Virtual Congress 2020 – Pulmonary embolism and beyond
Year: 2020
Prognostic value of the ECG on admission in patients with acute major pulmonary embolism
Source: Eur Respir J 2005; 25: 843-848
Year: 2005
Pulmonary embolism severity index and D-dimer for risk-stratification of patients with acute pulmonary embolism
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Year: 2010
Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism
Source: Eur Respir J 2004; 24: Suppl. 48, 277s
Year: 2004
Troponin T predicts in-hospital and 1-year mortality in patients with pulmonary embolism
Source: Eur Respir J 2009; 34: 1357-1363
Year: 2009
Biomarkers model for prediction of hospitalisation duration and pulmonary embolism outcome
Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Year: 2021
Hyperglycemia as a independent predictor of mortality in acute pulmonary embolism
Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism
Year: 2011
Effect of serum NT-proBNP and H-FABP levels in predicting extent of acute pulmonary thromboembolism
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Year: 2010
Pulmonary embolism severity index is superior to the Geneva score at predicting which patients with suspected pulmonary embolism are at increased risk of death
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008
Prediction of the severity of pulmonary embolism according to clinical pre-test and D-dimer concentration
Source: Eur Respir J 2006; 28: Suppl. 50, 402s
Year: 2006
Value of serum procalcitonin levels in the differential diagnosis of pneumonia and pulmonary embolism
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011
Short-term mortality in patients with acute symptomatic pulmonary embolism
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017
A radiomics nomogram based on CT pulmonary angiographic data for predicting adverse outcomes in non-high-risk acute pulmonary embolism patients
Source: International Congress 2018 – Acute pulmonary embolism: from diagnosis to treatment
Year: 2018
The use of pulmonary embolism severity index (PESI) score in identifying patients suitable for ambulatory treatment or early hospital discharge following diagnosis of pulmonary embolism
Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura
Year: 2012
Comparison of two clinical probability scores combined with C-reactive protein and D-dimer in the diagnosis of pulmonary embolism
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009
Pulmonary embolism severity index is useful in predicting mortality in patients investigated for query pulmonary embolism and negative CTPA
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept